Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
VERV | Verve Therapeutics, Inc. | Ashe Andrew D. | See Remarks | Aug 25, 2022 | Option Exercise | $1.59 | 95,787 | 152,217 | 266,509 | Aug 29, 2022, 05:00 PM | |
VERV | Verve Therapeutics, Inc. | Ashe Andrew D. | See Remarks | Dec 02, 2021 | Buy | $32.10 | 4,000 | 128,420 | 170,722 | Dec 06, 2021, 08:12 AM | |
DYAX | DYAX CORP | Ashe Andrew D. | General Counsel & EVP | Jan 14, 2016 | Option Exercise | $7.08 | 297,401 | 2,106,437 | 331,528 | Jan 15, 2016, 04:20 PM | |
DYAX | DYAX CORP | Ashe Andrew D. | General Counsel & EVP | Aug 03, 2015 | Option Exercise | $13.14 | 124,640 | 1,637,389 | 96,447 | Aug 05, 2015, 05:09 PM | |
DYAX | DYAX CORP | Ashe Andrew D. | General Counsel & EVP | Mar 06, 2015 | Sale | $15.50 | 2,400 | 37,200 | 34,127 | Mar 06, 2015, 04:16 PM | |
DYAX | DYAX CORP | Ashe Andrew D. | General Counsel & EVP | Feb 26, 2015 | Sale | $15.34 | 1,500 | 23,010 | 36,527 | Feb 26, 2015, 04:29 PM | |
DYAX | DYAX CORP | Ashe Andrew D. | General Counsel & EVP | Feb 27, 2014 | Option Exercise | $10.20 | 24,000 | 244,800 | 36,277 | Mar 03, 2014, 07:27 PM | |
DYAX | DYAX CORP | Ashe Andrew D. | General Counsel & EVP | Mar 03, 2014 | Option Exercise | $5.74 | 60,000 | 344,400 | 66,277 | Mar 03, 2014, 07:27 PM | |
DYAX | DYAX CORP | Ashe Andrew D. | General Counsel & Sr. VP, Adm. | Feb 26, 2014 | Sale | $10.10 | 2,723 | 27,502 | 12,277 | Feb 26, 2014, 04:07 PM | |
DYAX | DYAX CORP | Ashe Andrew D. | General Counsel & Sr. VP, Adm. | Aug 13, 2013 | Option Exercise | $2.96 | 65,000 | 192,439 | 47,500 | Aug 15, 2013, 04:18 PM |